Asceneuron's ASN51: Pioneering O-GlcNAcase Inhibitors to Combat Tau Protein Aggregation in Alzheimer's Disease
Neurodegenerative Disease Market Size and Growth Analysis The Neurodegenerative Disease Market is projected to grow significantly from 2024 to 2032, driven by advancements in treatment options and rising prevalence of conditions like Alzheimer’s, Parkinson’s, Huntington’s disease, and Multiple Sclerosis. Key drug types include cholinesterase inhibitors and dopamine agonists,...
0 Commenti 0 condivisioni 299 Views